Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Recruiting · NCT07426913 · Interventional (participants receive a specific treatment) · Lead sponsor: Virginia Commonwealth University
View the official record on ClinicalTrials.gov →Interventions studied
Cardiovascular Health Education and Gaming through Virtual Reality
What this trial is about
The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast Cancer survivors (n=30) learn about heart health. The aims are to test the usability, feasibility, and acceptability o the intervention. Additionally, follow-up assessments will examine changes in women's cancer therapy related cardiac dysfunction knowledge and heart healthy behaviors (e.g., physical activity).
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- 18 years of age or older
- Able to speak and read in English
- Actively receiving Trastuzumab or an anthracycline-based treatment
- Currently receiving immunotherapy. This includes pembrolizumab and atezolizumab.
- Diagnosed with stages 0-III Breast Cancer
Exclusion criteria
- \- History of prior Breast Cancer diagnosis (i.e., not their first breast cancer diagnosis)
Where it is running
3 locations listed across 1 US state.
- Adult Outpatient Pavilion - Richmond, Virginia, United States
- Cellular Immunotherapies and Transplant Department - Richmond, Virginia, United States
- VCU Health at Stony Point - Richmond, Virginia, United States